Last update - 16.10pm 17/07/2026 (20 minute delay)
?
| Day |
| Open |
$15.51 |
|
Day High |
$15.65 |
|
Day Low |
$14.73 |
| Daily Volume |
2136121 |
| Bids |
|
Sellers |
| Number |
Price |
Volume |
|
Number |
Price |
Volume |
| 0 |
$14.91 |
201 |
|
0 |
$14.92 |
1939 |
Directors & Senior Management
| Dr. Andreas Kluge |
Chief Medical Advisor |
| Dr. Chaitanya R. Divgi |
Member of the Scientific Advisory Board |
| Mr. Christian Davis |
Vice President Sales and Marketing, EMEA |
| Mr. Christian Krautkramer |
Group General Counsel |
| Dr. Christian P. Behrenbruch |
Co-Founder, MD, Group CEO & Executive Director |
| Mr. Craig Ulrick |
Chief Information Officer |
| Mr. Darren Patti |
Group Chief Operating Officer |
| Mr. Darren Smith |
Group Chief Financial Officer |
| Dr. David N. Cade |
Group Chief Medical Officer |
| Dr. Frederik L. Giesel |
Member of Scientific Advisory Board |
| Mr. James Stonecypher |
SVP of Global Therapeutics Development |
| Ms. Jann Elizabeth Skinner |
Independent Non-Executive Director |
| Prof. Jason S. Lewis |
Member of the Scientific Advisory Board |
| Prof. Jean-François Chatal |
Member of the Scientific Advisory Board |
| Dr. Kenneth G. Clarke |
Senior Vice President of Global Regulatory Affairs |
| Mr. Kevin Richardson |
Chief Executive Officer of Telix Precision Medicine |
| Dr. Klaus Kopka |
Member of the Scientific Advisory Board |
| Ms. Kyahn Williamson |
Senior Vice President of Corporate Communications & Investor Relations |
| Dr. Maria Rivas |
Independent Non-Executive Director |
| Ms. Marie E. McDonald |
Independent Non-Executive Director |
| Dr. Mark Alexander Nelson |
Interim Independent Non-Executive Chair |
| Dr. Mary Jessel |
Group Chief of Clinical Affairs |
| Ms. Meredith Crowe |
Senior Vice President of Global People & Culture |
| Ms. Michelle Hickey |
Senior Vice President of Global Manufacturing Operations |
| Dr. Neil H. Bander |
Member of the Scientific Advisory Board |
| Ms. Odile Jaume |
Advisor |
| Pamela Habib |
Chief Medical Officer of Therapeutics |
| Dr. Paul Schaffer |
SVP of Research & Development |
| Radu Ciocan |
Senior Vice President of TMS Radiopharmaceutical Operations |
| Mr. Raphael Ortiz |
Chief Executive Officer of Telix International |
| Prof. Richard P. Baum |
Member of the Scientific Advisory Board |
| Mr. Richard Valeix |
Chief Executive Officer of Telix Therapeutics |
| Dr. Richard Zimmermann |
Member of Scientific Advisory Board |
| Prof. Rodney W. Hicks |
Member of the Scientific Advisory Board |
| Prof. Samuel Samnick |
Member of the Scientific Advisory Board |
| Mr. Shomalin Naidoo |
Interim Company Secretary |
| Mr. Stefano Fanti |
Scientific Advisor |
| Thomas Fromm |
Vice President of Sales |
| Dr. Thorsten Melcher |
Senior Vice President of Global Business Development & Alliance Management |
| Mr. William R. Jellison |
Independent Non-Executive Director |
Data source: ADVFN
